Table of Contents

Executive Summary

1 Industry Overview of Anti-Asthmatic Drugs

• 1.1 Definition of Anti-Asthmatic Drugs
• 1.2 Anti-Asthmatic Drugs Segment by Type
  • 1.2.1 Global Anti-Asthmatic Drugs Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Long-term Control Medications
  • 1.2.3 Quick-relief Medications (Rescue Medications)
  • 1.2.4 Medications for Allergy-induced Asthma
• 1.3 Anti-Asthmatic Drugs Segment by Applications
  • 1.3.1 Global Anti-Asthmatic Drugs Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital Pharmacy
  • 1.3.3 Retail Pharmacy
  • 1.3.4 Online Pharmacy
• 1.4 Global Anti-Asthmatic Drugs Overall Market
  • 1.4.1 Global Anti-Asthmatic Drugs Revenue (2014-2025)
  • 1.4.2 Global Anti-Asthmatic Drugs Production (2014-2025)
  • 1.4.3 North America Anti-Asthmatic Drugs Status and Prospect (2014-2025)
  • 1.4.4 Europe Anti-Asthmatic Drugs Status and Prospect (2014-2025)
  • 1.4.5 China Anti-Asthmatic Drugs Status and Prospect (2014-2025)
  • 1.4.6 Japan Anti-Asthmatic Drugs Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Anti-Asthmatic Drugs Status and Prospect (2014-2025)
  • 1.4.8 India Anti-Asthmatic Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Anti-Asthmatic Drugs
• 2.3 Manufacturing Process Analysis of Anti-Asthmatic Drugs
• 2.4 Industry Chain Structure of Anti-Asthmatic Drugs

3 Development and Manufacturing Plants Analysis of Anti-Asthmatic Drugs

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Anti-Asthmatic Drugs Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Anti-Asthmatic Drugs
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Anti-Asthmatic Drugs Production and Capacity Analysis
• 4.2 Anti-Asthmatic Drugs Revenue Analysis
• 4.3 Anti-Asthmatic Drugs Price Analysis
• 4.4 Market Concentration Degree

5 Anti-Asthmatic Drugs Regional Market Analysis

• 5.1 Anti-Asthmatic Drugs Production by Regions
  • 5.1.1 Global Anti-Asthmatic Drugs Production by Regions
  • 5.1.2 Global Anti-Asthmatic Drugs Revenue by Regions
• 5.2 Anti-Asthmatic Drugs Consumption by Regions
• 5.3 North America Anti-Asthmatic Drugs Market Analysis
  • 5.3.1 North America Anti-Asthmatic Drugs Production
  • 5.3.2 North America Anti-Asthmatic Drugs Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Anti-Asthmatic Drugs Import and Export
• 5.4 Europe Anti-Asthmatic Drugs Market Analysis
  • 5.4.1 Europe Anti-Asthmatic Drugs Production
  • 5.4.2 Europe Anti-Asthmatic Drugs Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Anti-Asthmatic Drugs Import and Export
• 5.5 China Anti-Asthmatic Drugs Market Analysis
  • 5.5.1 China Anti-Asthmatic Drugs Production
  • 5.5.2 China Anti-Asthmatic Drugs Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Anti-Asthmatic Drugs Import and Export
• 5.6 Japan Anti-Asthmatic Drugs Market Analysis
  • 5.6.1 Japan Anti-Asthmatic Drugs Production
  • 5.6.2 Japan Anti-Asthmatic Drugs Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Anti-Asthmatic Drugs Import and Export
• 5.7 Southeast Asia Anti-Asthmatic Drugs Market Analysis
  • 5.7.1 Southeast Asia Anti-Asthmatic Drugs Production
  • 5.7.2 Southeast Asia Anti-Asthmatic Drugs Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Anti-Asthmatic Drugs Import and Export
• 5.8 India Anti-Asthmatic Drugs Market Analysis
  • 5.8.1 India Anti-Asthmatic Drugs Production
  • 5.8.2 India Anti-Asthmatic Drugs Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Anti-Asthmatic Drugs Import and Export

6 Anti-Asthmatic Drugs Segment Market Analysis (by Type)

• 6.1 Global Anti-Asthmatic Drugs Production by Type
• 6.2 Global Anti-Asthmatic Drugs Revenue by Type
• 6.3 Anti-Asthmatic Drugs Price by Type

7 Anti-Asthmatic Drugs Segment Market Analysis (by Application)

• 7.1 Global Anti-Asthmatic Drugs Consumption by Application
• 7.2 Global Anti-Asthmatic Drugs Consumption Market Share by Application (2014-2019)

8 Anti-Asthmatic Drugs Major Manufacturers Analysis

• 8.1 Abdi Ibrahim
  • 8.1.1 Abdi Ibrahim Anti-Asthmatic Drugs Production Sites and Area Served
  • 8.1.2 Abdi Ibrahim Product Introduction, Application and Specification
  • 8.1.3 Abdi Ibrahim Anti-Asthmatic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Ception Therapeutics
  • 8.2.1 Ception Therapeutics Anti-Asthmatic Drugs Production Sites and Area Served
  • 8.2.2 Ception Therapeutics Product Introduction, Application and Specification
  • 8.2.3 Ception Therapeutics Anti-Asthmatic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Elan
  • 8.3.1 Elan Anti-Asthmatic Drugs Production Sites and Area Served
  • 8.3.2 Elan Product Introduction, Application and Specification
  • 8.3.3 Elan Anti-Asthmatic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Innoviva
  • 8.4.1 Innoviva Anti-Asthmatic Drugs Production Sites and Area Served
  • 8.4.2 Innoviva Product Introduction, Application and Specification
  • 8.4.3 Innoviva Anti-Asthmatic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Novartis
  • 8.5.1 Novartis Anti-Asthmatic Drugs Production Sites and Area Served
  • 8.5.2 Novartis Product Introduction, Application and Specification
  • 8.5.3 Novartis Anti-Asthmatic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Sanofi
  • 8.6.1 Sanofi Anti-Asthmatic Drugs Production Sites and Area Served
  • 8.6.2 Sanofi Product Introduction, Application and Specification
  • 8.6.3 Sanofi Anti-Asthmatic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Mitsubishi Tanabe Pharma
  • 8.7.1 Mitsubishi Tanabe Pharma Anti-Asthmatic Drugs Production Sites and Area Served
  • 8.7.2 Mitsubishi Tanabe Pharma Product Introduction, Application and Specification
  • 8.7.3 Mitsubishi Tanabe Pharma Anti-Asthmatic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Menarini
  • 8.8.1 Menarini Anti-Asthmatic Drugs Production Sites and Area Served
  • 8.8.2 Menarini Product Introduction, Application and Specification
  • 8.8.3 Menarini Anti-Asthmatic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Dong-A Socio Holdings
  • 8.9.1 Dong-A Socio Holdings Anti-Asthmatic Drugs Production Sites and Area Served
  • 8.9.2 Dong-A Socio Holdings Product Introduction, Application and Specification
  • 8.9.3 Dong-A Socio Holdings Anti-Asthmatic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Lonza
  • 8.10.1 Lonza Anti-Asthmatic Drugs Production Sites and Area Served
  • 8.10.2 Lonza Product Introduction, Application and Specification
  • 8.10.3 Lonza Anti-Asthmatic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Sosei
• 8.12 Regeneron Pharmaceuticals
• 8.13 Theravance Biopharma
• 8.14 Lonza

9 Development Trend of Analysis of Anti-Asthmatic Drugs Market

• 9.1 Global Anti-Asthmatic Drugs Market Trend Analysis
  • 9.1.1 Global Anti-Asthmatic Drugs Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Anti-Asthmatic Drugs Regional Market Trend
  • 9.2.1 North America Anti-Asthmatic Drugs Forecast 2019-2025
  • 9.2.2 Europe Anti-Asthmatic Drugs Forecast 2019-2025
  • 9.2.3 China Anti-Asthmatic Drugs Forecast 2019-2025
  • 9.2.4 Japan Anti-Asthmatic Drugs Forecast 2019-2025
  • 9.2.5 Southeast Asia Anti-Asthmatic Drugs Forecast 2019-2025
  • 9.2.6 India Anti-Asthmatic Drugs Forecast 2019-2025
• 9.3 Anti-Asthmatic Drugs Market Trend (Product Type)
• 9.4 Anti-Asthmatic Drugs Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Anti-Asthmatic Drugs Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

The global Anti-Asthmatic Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Anti-Asthmatic Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Asthmatic Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Anti-Asthmatic Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Anti-Asthmatic Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abdi Ibrahim
Ception Therapeutics
Elan
Innoviva
Novartis
Sanofi
Mitsubishi Tanabe Pharma
Menarini
Dong-A Socio Holdings
Lonza
Sosei
Regeneron Pharmaceuticals
Theravance Biopharma
Lonza

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Long-term Control Medications
Quick-relief Medications (Rescue Medications)
Medications for Allergy-induced Asthma

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy